ENZON PHARMACEUTICALS, INC. (9)
Browse by Contract Category
Contracts
-
Description of Enzon Pharmaceuticals, Inc.s Registered Securities
(Filed With SEC on February 23, 2021)
-
Form of Subscription Agent Agreement
(Filed With SEC on September 15, 2020)
-
Amended and Restated Exclusive IP Marketing Agreement, dated as of June 28, 2004, by and between Microment AG and Enzon Pharmaceuticals, Inc
(Filed With SEC on February 21, 2019)
-
Form of Subscription Rights Certificate
(Filed With SEC on September 15, 2020)
-
INVESTMENTAGREEMENT BYAND BETWEEN ENZONPHARMACEUTICALS, INC. AND ICAHNCAPITAL LP DATEDAS OF SEPTEMBER 1, 2020
(Filed With SEC on September 1, 2020)
-
Investment Agreement, dated as of September 1, 2020, by and between the Registrant and Icahn Capital LP
(Filed With SEC on September 1, 2020)
-
Section 382Rights Agreement Datedas of August 14, 2020 byand between ENZON PHARMACEUTICALS, INC. and CONTINENTALSTOCK TRANSFER & TRUST COMPANY as Rights Agent
(Filed With SEC on August 14, 2020)
-
Description of Registrants Securities
(Filed With SEC on February 19, 2020)
-
Letter Agreement, dated January 30, 2019, between Servier IP UK Limited and Enzon Pharmaceuticals, Inc
(Filed With SEC on February 21, 2019)